ArticleBone marrow transplantation2018

Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.

Laura K Schmalbrock et al.PubMed ↗Publisher ↗

No numbers read from the abstract.